| PANDAS | Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections |
| PANS | Pediatric Acute-Onset Neuropsychiatric Syndrome |
| MBL | Mannose-binding lectin |
| TNF-α | Tumor necrosis factor alpha |
| OCD | Obsessive-compulsive disorders |
| ADHD | Attention-Deficit/Hyperactivity Disorder |
| GAS | Group A Streptococci |
| CaM kinase II | Calmodulin-dependent protein kinase II |
| IgM | Immunoglobulin M |
| TRAPS | Tumor Necrosis Factor Receptor Associated Periodic Syndrome |
| ASO | Antistreptolysin-O |
| SLITRK1 | Slit and Trk-like family member 1 |
| CELSR3 | Cadherin EGF LAG Seven-Pass G-Type Receptor 3 |
| FLT3 | FMS-like receptor tyrosine kinase-3 |
| COL27A1 | Collagen type XXVII alpha 1 chain |
| SLITRK5 | SLIT and NTRK-like protein 5 |
| HDC | Histidine decarboxylase |
| NRXN1 | Neurexin 1 |
| CNTN6 | Contactin 6 |
| DRD3 | Dopamine Receptor D3 |
| GDNF | Glial cell-derived neurotrophic factor |
| KCNJ5 | Potassium Voltage-Gated Channel Subfamily J Member 5 |
| AADAC | Arylacetamide Deacetylase |
| HCN4 | Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 |
| SSRI | Selective Serotonin Reuptake Inhibitor |
| MRI | Magnetic Resonance Imaging |
| PET | Positron Emission Tomography |
| IVIG | Intravenous immunoglobulin therapy |
| NSAID | Nonsteroidal anti-inflammatory drug |
| LPS | Lipopolysaccharide |
| NOX2 | NADPH oxidase 2 |
| ND | No data |